Gilead Sciences Deal History & Licensing Activity

About Gilead Sciences Licensing & Deal Activity

Gilead Sciences is a large pharma company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 48 deals over the past three years, Gilead Sciences ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Gilead Sciences include Infectious Disease (29 deals and trials), Oncology (23 deals and trials), Infectious (22 deals and trials), and Solid Tumors (13 deals and trials). In terms of modality, Gilead Sciences has shown particular interest in small molecules, small molecules, bispecific antibodies.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Gilead Sciences and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Gilead Sciences's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.